Rapport Therapeutics股价在盘前交易中暴涨75.5%,该公司公布的局灶性癫痫发作治疗药物中期试验数据表现良好,推动股价大幅上扬。
Rapport Therapeutics股价在盘前交易中暴涨75.5%,该公司公布的局灶性癫痫发作治疗药物中期试验数据表现良好,推动股价大幅上扬。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.